Items where authors include "McIlroy, G."

Article

Goodyear, C.S., Patel, A., Barnes, E. et al. (118 more authors) (2024) Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial. The Lancet Rheumatology, 6 (6). e339-e351. ISSN 2665-9913

Goodyear, C.S., Patel, A., Barnes, E. et al. (119 more authors) (2024) Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial. The Lancet Rheumatology, 6 (6). e339-e351. ISSN 2665-9913

McIlroy, G., Nikolousis, E., Abou-Zeid, N. et al. (9 more authors) (2020) Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation. Leukemia & Lymphoma, 61 (1). pp. 202-205. ISSN 1042-8194

Lloyd, R., Nikolousis, E., Kishore, B. et al. (11 more authors) (2020) Autoimmune cytopenias developing late post alemtuzumab-based allogeneic stem cell transplantation: presentation of short case series from a transplant center. Cell Transplantation, 29. ISSN 0963-6897

Horgan, C., Elmoamly, S., McIlroy, G. et al. (9 more authors) (2019) Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma : reflections on a single center experience. Leukemia & Lymphoma, 60 (12). pp. 3075-3077. ISSN 1042-8194